BOSSI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 103
EU - Europa 72
AS - Asia 16
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 195
Nazione #
US - Stati Uniti d'America 100
IT - Italia 34
FR - Francia 13
DE - Germania 6
IE - Irlanda 6
CN - Cina 5
PT - Portogallo 4
CA - Canada 3
FI - Finlandia 2
GB - Regno Unito 2
IL - Israele 2
IN - India 2
NL - Olanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
GH - Ghana 1
IQ - Iraq 1
JP - Giappone 1
RU - Federazione Russa 1
SG - Singapore 1
TR - Turchia 1
TW - Taiwan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 195
Città #
Seattle 10
Fairfield 9
Houston 8
Milan 8
Santa Cruz 8
Columbus 7
Woodbridge 7
Cambridge 6
Dublin 6
Buffalo 5
Ashburn 4
Rio de Mouro 4
Shanghai 4
Wilmington 4
Frankfurt am Main 3
Modena 3
Toronto 3
Ahi'ezer 2
Amsterdam 2
Boardman 2
Bologna 2
Carate Brianza 2
Casorate Primo 2
Chennai 2
Los Angeles 2
Rome 2
San Francisco 2
Seveso 2
Turin 2
Ankara 1
Brisbane 1
Bucharest 1
Chicago 1
Clearwater 1
Erbil 1
Gunzenhausen 1
Hanoi 1
Helsinki 1
Henderson 1
Indiana 1
Kyoto 1
Lappeenranta 1
Las Vegas 1
Lecce 1
Lombard 1
Malnate 1
Marburg 1
Monza 1
Muizenberg 1
New York 1
Phoenix 1
Prad am Stilfser Joch 1
Riva 1
Saint Petersburg 1
Satu Mare 1
Shulin District 1
Singapore 1
Tower Hamlets 1
University Park 1
Veniano 1
Totale 154
Nome #
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization, file e39773b6-422d-35a3-e053-3a05fe0aac26 112
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia, file 5c471a21-cb11-4602-b96a-0a53c519def4 25
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706), file 5e456eae-4aaf-4615-9e27-02321f774770 22
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi, file ea09c0e1-ca76-4b9e-834a-6874da71604d 21
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas, file 01194b51-9a89-4815-a965-374df2b4d001 19
Totale 199
Categoria #
all - tutte 726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 2 5 5 4 4 3 0
2020/202135 4 1 3 1 2 2 5 3 3 2 5 4
2021/202223 1 0 3 1 2 1 0 3 1 1 8 2
2022/202327 2 3 9 3 1 0 1 1 0 0 5 2
2023/202491 4 3 6 7 6 11 14 13 8 6 13 0
Totale 199